Estrogen And Alzheimers Disease

Estrogen's role in Alzheimer's disease has been a subject of significant research. Estrogen, a hormone primarily associated with female reproductive health, also influences brain function, including memory and cognition. Studies suggest that estrogen may have neuroprotective effects, potentially reducing the risk of Alzheimer's disease in women. However, the relationship is complex, as estrogen's benefits seem to vary depending on age, timing of hormone exposure (such as menopausal status), and individual genetic factors. Some research indicates that estrogen therapy after menopause might help maintain cognitive function and reduce the risk of dementia. Yet, the use of estrogen therapy remains controversial due to associated risks, such as cardiovascular complications and certain types of cancer. Further research is crucial to clarify estrogen's precise role in Alzheimer's disease and to develop safer therapeutic strategies.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Tags
Facebook
Watsapp